Suspected Intracranial Hypertension (SICH)
- Definition:
- 1 or more major criteria or
- 2 or more minor criteria
- Major Criteria:
- Compressed cisterns (Marshall diffuse injury III)
- Midline shift > 5 mm (Marshall diffuse injury IV)
- Non-evacuated mass lesion of 25 cm³ or more
- Minor Criteria:
- GCS score of ≤ 4
- Pupillary asymmetry
- Abnormal pupillary reactivity
- CT classification of Marshall diffuse injury II (i.e., basal cisterns are present with midline shift 0-5 mm and/or high- or mixed-density lesion of 25 cm³ or less)
Tiered management for paediatric head injury (Global Neuro Trauma)
Tier One
- Elevate CPP to an age-appropriate level (CPPa + 10 mm Hg)
- Targeted Temperature Management
- Maintain temperature 36.5°C - 38.0°C (Infrared)
- Increase sedation to treat intracranial hypertension
- Increase analgesia to treat intracranial hypertension
- PaCO₂ 35 - 38 mm Hg / 4.6 - 5.0 kPa
- Corrected for altitude
- Mannitol by bolus (e.g., 0.25 - 1.0 g/kg) for ICH
- HS by bolus (e.g., 2 - 5 mL/kg of 3% NaCl) for ICH
- Consider EVD placement to drain CSF for ICH
- Consider epilepsy prophylaxis x 7 days
- Consider EEG monitoring
Management of Pediatric Severe Traumatic Brain Injury: 2019... : Pediatric Critical Care Medicine (lww.com)
flowchart TD subgraph V["PbrO2 Pathway"] V2["Raised FiO2"] V1["Maintain PbrO2 >10mmHg"] V3["Vasopressor, Hyperventilate, optimize Hb"] end subgraph W["CPP Pathway"] W2["Confirm appropriate CVP (CVP 8-12 mmHg)"] W1["Maintain CPP >40mmHg"] W3["Bolus hypertonic saline"] W4["Vasopressor use"] end subgraph X["ICP Pathway"] X2["Bolus and/or infusion of hypertonic saline"] X1["CSF drainage if ventriculostomy present"] X3["Additional analgesia/sedation"] X4["Neuromuscular blockade"] X5["Additional hypertonic saline<br>/hyperosmolar therapy"] end subgraph Y["Herniation Pathway"] Y2["Emergency treatment:<br>Hyperventilation therapy to reverse pupillary dilation<br>FiO2=1.0<br>Bolus of IV hypertonic saline or mannitol<br>Open EVD to continuous drainage<br>Emergency CT"] Y1["If signs and symptoms of herniation:<br>Pupillary dilation<br>Hypertension/bradycardia<br>Extensor posturing"] end U1["TBI (GCS ≤ 8)"] --> U2["Cranial CT"] U2 --> U3["Insert ICP Monitor"] & U5["Surgery if target found"] U3 --> U4["Maintain appropriate analgesia/Sedation<br>Maintain Normothermia<br>Ensure appropriate intravscular volume (CVP)<br>Mainatain Hb>7<br>Treat coagulopathy<br>Elevate head 30 deg<br>Consider antiepileptics (Keppra/Phenytoin)/EEG<br>Start nutrition as early as possible"] U4 --> V & W & X & Y V1 -- if PbrO2 still low --> V2 V2 -- if PbrO2 still low --> V3 W1 -- if CPP still low --> W2 W2 -- if CPP still low --> W3 W3 -- if CPP still low --> W4 X1 -- "if ICP still raised (ICP > 20-25 for > 5 min;<br>major priority if ICP > 25 mmHg)" --> X2 X2 -- if ICP still raised --> X3 X3 -- if ICP still raised --> X4 X4 -- if ICP still raised --> X5 Y1 --> Y2 X5 --> Z["Second tier therapy"] Y2 --> Z V3 --> Z W4 --> Z Z --> A["↑ ICP Refractory to <br>first tier therapies"] A --> B["Repeat CT scan (if surgical <br>option is being considered)"] B --> C{"New or expanding<br>surgical lesion"} C -- YES --> D["Surgery as indicated"] C -- NO --> F["Barbiturate infusion²"] & G["Moderate hypothermia³<br>32-34°C"] & H["Hyperventilation⁴<br>28-34 mmHg"] & I["Higher levels of<br>osmolar therapy⁵"] & J["Consider additional advanced neuro-monitoring<br>EEG, TCD, PRx, CBF"] D --> E["Surgical intervention:<br>Remove mass lesion and/or<br>decompressive craniectomy¹"] style U4 fill:#000000 style V fill:#AA00FF style W fill:#FF6D00 style X fill:#FFD600 style Y fill:#00C853
²Active EEG and no medical contraindications
³No contraindications
⁴Strongly consider advanced neuro-monitoring for ischemia
⁵Advance dose of 3% saline or mannitol, or use both as 23.4% saline. If possible, avoid serum sodium concentrations of > 160 mEq/L and serum osmolarity of > 360 mOsm/L
- Key
- The algorithm includes several components
- benzodiazepine-opiate (Midazolam-morphine/fentanyl) combination for initial sedative/analgesic therapy.
- Mechanical ventilation target
- PaO2: 90–100 mmHg. 12-13Kpa
- Minute ventilation target: PaCO2: 35-40mmHg 4.6-5.3Kpa
- Intravascular volume target
- Euvolemia: targeting normovolemia requires at least 75% maintenance fluids and that a neutral fluid balance should be achieved with a urine flow rate of greater than 1 mL/kg/hr
- Fluids: Normal saline in general
- Can use 5% dextrose + NS in younger children to prevent hypoglycemia
- Glucose target
- Normoglycaemia: 180 mg/dL (10mmol/L)
- Use insulin if glucose level is greater than 198 mg/dL (11mmol/L) on two consecutive measurements
- Na limits
- 135 mEq/L between 150 mEq/L
- With hyperosmolar therapy it can go higher than 150mEq/L
- Coagulopathy
- Treatment of abnormal coagulation variables is recommended prior to
- Keep INR < 1.6 with FFP before insertion of ICP or Pbro2 monitors
- Keep INR < 1.2 with FFP before decompressive craniectomy
- Caution: Overresuscitation with plasma to normalize INR after TBI in children may worsen coagulopathy, producing fibrinolysis shutdown, and that treatment of coagulopathy should address active bleeding and/or be titrated to thromboelastography
- Antiseizure
- EEG monitor esp when neuromuscular blockade
- Keppra prefered
- No consensus on who to start -- up to you
- ICP Pathway (yellow)
- Targets
- < 20 mm Hg as an initial ICP target in all age groups
- need for an intervention when ICP is > 20 mm Hg for at least 5 minutes.
- Herniation Pathway (green),
- Emergent tx in the herniation pathway
- manual hyperventilation with Fio2 of 1.0, titrated to reversal of pupillary dilation;
- administration of
- mannitol (0.5–1 g/kg) over 10 minutes, or
- Upper limit 320 mOsm/L
- hypertonic saline (3%; 1–3 mL/kg, up to a maximum dose of 250 mL, or 23.4%, 0.5 mL/kg, maximum dose of 30 mL) over 10mins;
- Upper limit 360 mOsm/L
- maintenance of hemodynamic stability
- Cerebral Perfusion Pressure (CPP) Pathway (orange),
- Target: >40mmHg
- Implicit in the CPP pathway is the practice of tolerating mild intracranial hypertension in the presence of adequate CPP (“permissive intracranial hypertension”) as an alternative to immediate initiation of second tier therapies.
- Brain Tissue Partial Pressure of Oxygen (Pbro 2) Pathway (Purple).
- Target >10mmHg
- Raise PbrO2 with
- hypoventilation
- Inc. FiO2
- The blue box indicates the need for second tier therapy
- Solid lines identify the ICP and CPP pathways, reflecting their primary role,
- Dashed line identifies the Pbro 2 pathway given the fact that it represents a monitoring and management option that is less commonly used and has less literature support.
- Dotted plus dashed line identifies the weaning or withdrawal of the various interventions.
- BUN = blood urea nitrogen, CVP = central venous pressure, EEG = electroencephalogram, EVD = external ventricular drain, GCS = Glasgow Coma Scale, Fio 2 = fraction of inspired oxygen, Hgb = hemoglobin, HOB = head of bed.
Baseline Care (black)
- Minimal Targets
CPP | 40 mm Hg |
PbrO2 | 10 mm Hg |
Hb | 7 g/dL |
ICP | <20mmHg |
- For treatment of refractory intracranial hypertension when tier 1 approaches are inadequate.
- CBF = cerebral blood flow, EEG = electroencephalogram, ICP = intracranial pressure, PRx = pressure reactivity index, TCD = transcranial Doppler ultrasonography.
- Barbiturate
- Pentobarbital
- Indicated
- osmotherapy and hyperventilation have failed to maintain ICP less than 25 mmHg
- If barbiturate infusion fails to control ICP, as defined by persistent ICP greater than 25 mm Hg, decompressive craniectomy, or one of the other second tier therapies, should be considered,
- If barbiturate infusion works (ICP maintained <20 mm Hg for 24 hours while receiving a stable pentobarbital infusion dose) the infusion can be decreased and then withdrawn over 24–96 hours.
- Hypothermia
Early moderate hypothermia has been tested in clinical trials and is not recommended- Hutchinson 2008
andBeca et al 2015 - Hypothermia has poorer outcome and mortality
- Late Hypothermia can be used (32-34 deg)
- Only used in some studies but not studied in RCT
Weaning of therapy
- the interventions are withdrawn in the reverse order of their application.
- Need to show 24 hrs of stability before starting to wean
Therapy summary
Therapy | Guidance |
CPP | A minimum CPP of 40 mmHg may be considered in children with TBI. A CPP threshold of 40-50 mmHg may be considered; there may be age-specific thresholds with infants at the lower end and adolescents at the upper end of this range. |
Brain oxygenation | If brain oxygen monitoring is used, maintenance of oxygen tension ≥10 mmHg may be considered. |
Hyperosmolar therapy | 3% hypertonic saline (0.1-1 mL/kg of body weight per hour) should be considered for the treatment of intracranial hypertension. |
Hyperventilation | Avoidance of prophylactic severe hyperventilation to a PaCO₂ <30 mmHg may be considered in the initial 48 h after injury. If hyperventilation is used in the management of refractory intracranial hypertension, advanced neuromonitoring for evaluation of cerebral ischemia may be considered. |
Temperature control | Moderate hypothermia (32-33 °C) beginning early after severe TBI for only 24-h duration should be avoided. Moderate hypothermia (32-33 °C) beginning within 8 h after severe TBI for up to 48-h duration should be considered to reduce intracranial hypertension. If hypothermia is induced for any reason, rewarming at a rate of >0.5 °C/h should be avoided. |
Barbiturates | High-dose barbiturate therapy may be considered in hemodynamically stable patients with refractory intracranial hypertension despite maximal medical and surgical management. When high-dose barbiturate therapy is used to treat refractory intracranial hypertension, continuous arterial blood pressure monitoring and cardiovascular support to maintain adequate cerebral perfusion pressure are required. |
Corticosteroids | The use of corticosteroids is not recommended to improve outcome or reduce ICP for children with severe TBI. |
Anesthetic drugs | Etomidate may be considered to control severe intracranial hypertension; however, the risks resulting from adrenal suppression must be considered. Thiopental may be considered to control intracranial hypertension. As stated by the FDA, a continuous infusion of propofol for either sedation or the management of refractory intracranial hypertension in infants and children with severe TBI is not recommended. |
Antiseizure drugs | Prophylactic use of antiseizure therapy is not recommended for children with severe TBI for preventing late post-traumatic seizures. Prophylactic antiseizure therapy may be considered as a treatment option to prevent early post-traumatic seizures in young pediatric patients and infants at high risk of seizures after head injury. |
Nutrition | Evidence does not support the use of immune-modulating diet to improve outcome. |
- Consider ICP monitoring in infants and children with severe TBI and treating when ICP exceeds 20-25 mmHg.